Mind Medicine Inc

Ichnos Sciences Inc is a New York-based biotechnology company that is dedicated to revolutionizing the field of medicine. With a focus on oncology and autoimmune diseases, Ichnos Sciences aims to make significant advancements in disease understanding and develop life-changing therapies. Driven by a mission of change, Ichnos Sciences combines start-up spirit with experienced leadership to take scientific risks and tackle the greatest challenges in medicine, providing physicians and patients with not just hope, but tangible progress.Generated from the website

Celmatix Inc., based in New York City and Cambridge, MA, is a preclinical-stage biotechnology company focused on pioneering innovative therapies specifically for women's health, particularly in the realm of ovarian health. With a growing pipeline that includes programs targeting ovarian aging, infertility, and endometriosis, Celmatix aims to address significant unmet medical needs and advance the understanding of female biology. Recognized for its groundbreaking research, Celmatix has received substantial funding from the Advanced Research Projects Agency for Health (ARPAH) to accelerate its drug development initiatives. The company's commitment to creating tailored therapeutics reflects its belief that women deserve specialized treatments to enhance their health and longevity throughout their lives. Generated from the website

The Global Alliance for TB Drug Development Inc., based in New York, is a pioneering organization dedicated to the research and development of new and effective treatments for tuberculosis (TB). With a mission to transform TB therapy, the Alliance manages the largest pipeline of new TB drugs in history, aiming to make innovative treatments accessible to all who need them. Celebrating 25 years of commitment to eradicating TB, the organization focuses on developing faster, simpler, and more effective cures for the disease, particularly drug-resistant forms of TB. Through collaborations and initiatives like the multi-manufacturer strategy, the Alliance works tirelessly to ensure that advancements in TB treatment are available globally, reinforcing the idea that access to treatment is a fundamental human right. Generated from the website